While cardiac damage reverses in many patients following treatment, it can actually continue to get worse in others. 

Contact force-sensing catheters were developed to help overcome the issue of incomplete ablation lesions.

"Psychologists have had little involvement in the care of cardiac patients but this needs to change," one researcher said in a statement. 

Jonathan Lindner, MD, offers an update on the use of echocardiography and bubble contrast agents in a therapy role to help revascularize STEMI patients and increase drug and gene delivery.

The new device was designed to remove thrombi and emboli from peripheral arteries ranging from 2 to 4 mm. 

Cardiologists and other physicians have always believed cardiac transthyretin amyloidosis, a progressive heart condition associated with a high mortality rate, was irreversible. Now, though, new evidence suggests that there may be hope. 

Cedars-Sinai researchers are developing a deep-learning algorithm to personalize patient cardiac risk predictions in a patient-friendly, graphical report.

Pulsed field ablation is one of the biggest technology trends in cardiac electrophysiology and may become a new standard of care in atrial fibrillation the coming years based on clinical data.